BioSpace News Archive

Drug Development

Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of FP-045, a Potent ALDH2 Activator

Foresee Pharmaceuticals Co., Ltd. announced that it has successfully completed a Phase 1 multiple ascending dose (MAD) clinical study with FP-045

July 26, 2018
·
3 min read
Business

McKesson Reports Fiscal 2019 First-Quarter Results

Revenues of $52.6 billion for the first quarter, up 3% year over year.

July 26, 2018
·
28 min read
Business

Celgene Reports Second Quarter 2018 Operating and Financial Results

Strong total net product sales of $3.8 billion, increased 17% Y/Y

July 26, 2018
·
29 min read
Business

NXT-ID Appoints Robert A. Curtis to Board of Directors

Bioscience veteran brings 35 years of health care industry experience to the Board

July 26, 2018
·
5 min read
Drug Development

Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme’s ENHANZE® Technology

Subcutaneous administration using Halozyme’s proprietary ENHANZE® drug-delivery technology in combination with chemotherapy.

July 26, 2018
·
4 min read
Policy

Immunexpress Receives Notice of U.S. Patent Allowance for SeptiCyte™ Technology to Quantify Biomarkers

The allowance complements the Company’s growing patent portfolio of gene technology in the detection of host response to sepsis

July 26, 2018
·
3 min read
Bio NC

Semiconductor Research Corporation Releases $26 Million in New Research Funds

JUMP program funds 24 new research projects to amplify mission of its six innovation centers

July 26, 2018
·
2 min read
Lone Star Bio

Asuragen Expands AmplideX® Technology and Product Line with Launch of PCR/CE SMN1 Kit

The AmplideX PCR/CE SMN1 kit allows laboratories to quickly and easily determine SMN1 exon 7 copy number

July 26, 2018
·
2 min read
Drug Development

Proclara Biosciences Announces Initiation of NPT189 Clinical Development for Systemic Amyloidoses and Provides Pipeline Update

First Subject Dosed in Phase 1a Trial of NPT189, Broadening Clinical Pipeline with Next Generation GAIM-Based Therapy Targeting Orphan Indications

July 26, 2018
·
4 min read
Dr. Reddy’s Laboratories Announces the Launch of Hervycta® (trastuzumab biosimilar) in India

Dr. Reddy’s Laboratories Ltd. announced today that it has launched Hervycta® (trastuzumab)

July 26, 2018
·
3 min read